BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 29132266)

  • 1. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Thillainayagam M; Malathi K; Ramaiah S
    J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CF
    Agoni C; Salifu EY; Munsamy G; Olotu FA; Soliman M
    Chem Biodivers; 2019 Dec; 16(12):e1900365. PubMed ID: 31589372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel quinoline-appended chalcone derivative as potential
    Kumar H; Wadi I; Devaraji V; Pillai CR; Ghosh SK
    J Vector Borne Dis; 2019; 56(3):189-199. PubMed ID: 32655067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors.
    Azeredo LFSP; Coutinho JP; Jabor VAP; Feliciano PR; Nonato MC; Kaiser CR; Menezes CMS; Hammes ASO; Caffarena ER; Hoelz LVB; de Souza NB; Pereira GAN; Cerávolo IP; Krettli AU; Boechat N
    Eur J Med Chem; 2017 Jan; 126():72-83. PubMed ID: 27744189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydro-1H,5H-pyrazolo[1,2-a]pyrazole-1-carboxylates as inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Strašek N; Lavrenčič L; Oštrek A; Slapšak D; Grošelj U; Klemenčič M; Brodnik Žugelj H; Wagger J; Novinec M; Svete J
    Bioorg Chem; 2019 Aug; 89():102982. PubMed ID: 31132601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Design, and Structure⁻Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of
    Xu L; Li W; Diao Y; Sun H; Li H; Zhu L; Zhou H; Zhao Z
    Molecules; 2018 May; 23(6):. PubMed ID: 29794978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
    Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
    Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase.
    Wadood A; Ulhaq ZU
    J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds.
    Deng X; Gujjar R; El Mazouni F; Kaminsky W; Malmquist NA; Goldsmith EJ; Rathod PK; Phillips MA
    J Biol Chem; 2009 Sep; 284(39):26999-7009. PubMed ID: 19640844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interconvertible geometric isomers of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors exhibit multiple binding modes.
    McConkey GA; Bedingfield PTP; Burrell DR; Chambers NC; Cunningham F; Prior TJ; Fishwick CWG; Boa AN
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3878-3882. PubMed ID: 28669445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.
    Hou X; Chen X; Zhang M; Yan A
    SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitors of the Plasmodium falciparum electron transport chain.
    Stocks PA; Barton V; Antoine T; Biagini GA; Ward SA; O'Neill PM
    Parasitology; 2014 Jan; 141(1):50-65. PubMed ID: 24401337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 3,4-Dihydro-2
    Hartuti ED; Sakura T; Tagod MSO; Yoshida E; Wang X; Mochizuki K; Acharjee R; Matsuo Y; Tokumasu F; Mori M; Waluyo D; Shiomi K; Nozaki T; Hamano S; Shiba T; Kita K; Inaoka DK
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281290
    [No Abstract]   [Full Text] [Related]  

  • 16. Design and synthesis of chalcone derivatives as inhibitors of the ferredoxin - ferredoxin-NADP+ reductase interaction of Plasmodium falciparum: pursuing new antimalarial agents.
    Suwito H; Jumina ; Mustofa ; Pudjiastuti P; Fanani MZ; Kimata-Ariga Y; Katahira R; Kawakami T; Fujiwara T; Hase T; Sirat HM; Puspaningsih NN
    Molecules; 2014 Dec; 19(12):21473-88. PubMed ID: 25532844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Intramolecular Hydrogen Bond on the Active Metabolite Analogs of Leflunomide for Blocking the Plasmodium falciparum Dihydroorotate Dehydrogenase Enzyme: QTAIM, NBO, and Docking Study.
    Heidarian R; Zahedi-Tabrizi M
    Curr Comput Aided Drug Des; 2021; 17(3):480-491. PubMed ID: 32459610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coptisine, a natural alkaloid from Coptidis Rhizoma, inhibits plasmodium falciparum dihydroorotate dehydrogenase.
    Lang L; Hu Q; Wang J; Liu Z; Huang J; Lu W; Huang Y
    Chem Biol Drug Des; 2018 Jul; 92(1):1324-1332. PubMed ID: 29582555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity.
    Kokkonda S; Deng X; White KL; Coteron JM; Marco M; de Las Heras L; White J; El Mazouni F; Tomchick DR; Manjalanagara K; Rudra KR; Chen G; Morizzi J; Ryan E; Kaminsky W; Leroy D; Martínez-Martínez MS; Jimenez-Diaz MB; Bazaga SF; Angulo-Barturen I; Waterson D; Burrows JN; Matthews D; Charman SA; Phillips MA; Rathod PK
    J Med Chem; 2016 Jun; 59(11):5416-31. PubMed ID: 27127993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.